In the article, "Search and Selection of Probiotics That Improve Mucositis Symptoms in Oncologic Patients. A Systematic Review" [1] which appears in Volume 11, Issue 10 of Nutrients, there is a correction on the official term of the drug name used in the article.
As De Simone [2] points out, The drug term VSL#3 ® is replaced with the generic name of the formulation, "De Simone formulation", following a legal dispute between the distributors of the product VSL#3 ® and the formula inventor.
This change does not affect the study of the paper.
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